scholarly journals Molecular surveillance of chloroquine drug resistance markers (Pfcrt and Pfmdr1) among imported Plasmodium falciparum malaria in Qatar

2017 ◽  
Vol 112 (2) ◽  
pp. 57-62 ◽  
Author(s):  
Anushree Acharya ◽  
Devendra Bansal ◽  
Praveen K. Bharti ◽  
Fahmi Y. Khan ◽  
Salem Abusalah ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Falciparum Malaria ◽  
Plasmodium Falciparum Malaria ◽  
Molecular Surveillance ◽  
Resistance Markers

scholarly journals Molecular Surveillance of Plasmodium falciparum Drug Resistance Markers in Clinical Samples from Botswana

2018 ◽  
Vol 99 (6) ◽  
pp. 1499-1503 ◽  
Author(s):  
Leabaneng Tawe ◽  
Michela Menegon ◽  
Pleasure Ramatlho ◽  
Charles W. Muthoga ◽  
Naledi Mutukwa ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Clinical Samples ◽  
Molecular Surveillance ◽  
Resistance Markers

scholarly journals Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria

2020 ◽  
Vol 13 (1) ◽  
Author(s):  
Monday Tola ◽  
Olumide Ajibola ◽  
Emmanuel Taiwo Idowu ◽  
Olusesan Omidiji ◽  
Samson Taiwo Awolola ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Antimalarial Drug Resistance ◽  
Allelic Discrimination ◽  
Molecular Surveillance ◽  
Malaria Burden ◽  
Two Samples ◽  
Southwest Nigeria ◽  
Resistance Markers ◽  
Drug Interventions

Abstract Objective Nigeria bears 25% of global malaria burden despite concerted efforts towards its control and elimination. The emergence of drug resistance to first line drugs, artemisinin combination therapies (ACTs), indicates an urgent need for continuous molecular surveillance of drug resistance especially in high burden countries where drug interventions are heavily relied on. This study describes mutations in Plasmodium falciparum genes associated with drug resistance in malaria; Pfk13, Pfmdr1, PfATPase6 and Pfcrt in isolates obtained from 83 symptomatic malaria patients collected in August 2014, aged 1–61 years old from South-west Nigeria. Results Two Pfmdr1, N86 and Y184 variants were present at a prevalence of 56% and 13.25% of isolates respectively. There was one synonymous (S679S) and two non-synonymous (M699V, S769M) mutations in the PATPase6 gene, while Pfcrt genotype (CVIET), had a prevalence of 45%. The Pfk13 C580Y mutant allele was suspected by allelic discrimination in two samples with mixed genotypes although this could not be validated with independent isolation or additional methods. Our findings call for robust molecular surveillance of antimalarial drug resistance markers in west Africa especially with increased use of antimalarial drugs as prophylaxis for Covid-19.

scholarly journals Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite

2012 ◽  
Vol 109 (32) ◽  
pp. 13052-13057 ◽  
Author(s):  
D. J. Park ◽  
A. K. Lukens ◽  
D. E. Neafsey ◽  
S. F. Schaffner ◽  
H.-H. Chang ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Falciparum Malaria ◽  
Malaria Parasite ◽  
Plasmodium Falciparum Malaria

scholarly journals Molecular detection of drug resistant polymorphisms in Plasmodium falciparum isolates from Southwest, Nigeria.

2020 ◽  
Author(s):  
Monday Tola ◽  
Olumide Ajibola ◽  
Taiwo Emmanuel Idowu ◽  
Olusesan Omidiji ◽  
Samson Taiwo Awolola ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Antimalarial Drug Resistance ◽  
Allelic Discrimination ◽  
Molecular Surveillance ◽  
Malaria Burden ◽  
Two Samples ◽  
Southwest Nigeria ◽  
Resistance Markers ◽  
Drug Interventions

Abstract ObjectiveNigeria bears 25% of global malaria burden despite concerted efforts towards its control and elimination. The emergence of drug resistance to first line drugs, artemisinin combination therapies (ACTs), indicates an urgent need for continuous molecular surveillance of drug resistance especially in high burden countries where drug interventions are heavily relied on. This study describes mutations in Plasmodium falciparum genes associated with drug resistance in malaria; Pfk13, Pfmdr1, PfATPase6 and Pfcrt in isolates obtained from 83 symptomatic malaria patients collected in August 2014, aged 1-61 years old from South-west Nigeria. ResultsTwo Pfmdr1, N86 and Y184 variants were present at a prevalence of 56% and 13.25% of isolates respectively. There was one synonymous (S679S) and two non-synonymous (M699V, S769M) mutations in the PATPase6 gene, while Pfcrt genotype (CVIET), had a prevalence of 45%. The Pfk13 C580Y mutant allele was suspected by allelic discrimination in two samples with mixed genotypes although this could not be validated with independent isolation or additional methods. Our findings call for robust molecular surveillance of antimalarial drug resistance markers in west Africa especially with increased use of antimalarial drugs as prophylaxis for Covid-19.

scholarly journals Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis protocol

2020 ◽  
Author(s):  
Peter Thelma Ngwa Niba ◽  
Akindeh M. Nji ◽  
Marie-Solange Evehe ◽  
Innocent M. Ali ◽  
Palmer Masumbe Netongo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Drug Resistance ◽  
Plasmodium Falciparum ◽  
Falciparum Malaria ◽  
Meta Analysis ◽  
Rapid Development ◽  
Gene Mutations ◽  
Pool Data ◽  
Mesh Terms ◽  
Resistance Markers

Abstract Background: Cameroon remains a country faced with high malaria burden despite enormous efforts made in the control of the disease. The rapid development and dispersal of mutations associated with anti-malarial drug resistance influenced policy changes from the use of chloroquine, amodiaquine and sulphadoxine-pyrimethamine to the adoption of artemisinin-based combination therapies (ACTs) for the treatment of uncomplicated falciparum malaria. Different studies have identified the frequency of key markers in Plasmodium falciparum associated with drug resistance without a clear picture on the localisation of potential hotspots that may drive the emergence of resistance to the currently used ACTs. This systematic review and meta-analysis aims to determine the prevalence and distribution of P. falciparum drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon from 1990 to present. Methods: The PRISMA, PRISMA-P and STREGA statements will be adopted in the quality assessments of studies to be included in this review. The electronic databases of Medline via Pubmed, EMBASE, Google Scholar and Science Direct will be searched by two independent researchers using different MeSH terms and Boolean operators (AND, OR). More so, unpublished data that will be sourced from academic libraries will also be extracted. Quantitative syntheses will be done using the “metaphor” and “meta” commands in the R statistical software package version 3.5.2. Heterogeneity will be assessed using the Cochrane Q and I2 statistics. The random effects model will be used as benchmark in the determination of heterogeneity between studies. Discussion: The primary outcome of this review is to identify and describe molecular markers conferring drug resistance in Plasmodium falciparum parasites that have been circulating for a period of over 30 years in Cameroon. This review will be able to pool data from previously published and unpublished studies on anti-malarial drug resistance gene mutations. This will provide evidence to support the continuous use of ACTs in the treatment of uncomplicated P. falciparum malaria. Moreover, it is also hoped that potential hotspots driving the emergence and spread of anti-malarial resistance markers will be identified. Systematic review registration: PROSPERO CRD42020162620

Sign in / Sign up

Export Citation Format

Share Document